Jules Bordet Institute
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1939-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.bordet.be
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
Phase 2
Recruiting
- Conditions
- Peritoneal CarcinomatosisCancer
- Interventions
- Diagnostic Test: FAPI PET/CT
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 80
- Registration Number
- NCT06061874
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.
Phase 2
Recruiting
- Conditions
- TNBC - Triple-Negative Breast Cancer
- Interventions
- Diagnostic Test: Ga-PSMA PET/CT
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 20
- Registration Number
- NCT06059469
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
Efficacy and Safety of SCRT Versus TNT in Older Patients With Locally Advanced Rectal Cancer
Not Applicable
Recruiting
- Conditions
- Locally Advanced Rectal CancerOlder People
- Interventions
- Radiation: Short course radiotherapyDrug: Adjuvant chemotherapy (optional)Combination Product: Total neoadjuvant therapyProcedure: Total mesorectal excision
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 230
- Registration Number
- NCT06052332
- Locations
- 🇧🇪
UZA Antwerpen, Edegem, Antwerpen, Belgium
🇧🇪Institut Jules Bordet, Anderlecht, Brussels, Belgium
🇧🇪Chirec Delta, Auderghem, Brussels, Belgium
To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT
Not Applicable
Recruiting
- Conditions
- Gynecologic Cancer
- Interventions
- Device: Vaginal dilatatorsDevice: MonaLisa Touch device
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 136
- Registration Number
- NCT05891470
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)
Not Applicable
Completed
- Conditions
- Bowel DysfunctionRadiotherapy Side EffectQuality of LifeProstate Cancer
- Interventions
- Other: Bowel symptoms & QoL assessment
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 41
- Registration Number
- NCT05880446
- Locations
- 🇧🇪
Institut Jules Bordet, Anderlecht, Bruxelles, Belgium
Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features
Not Applicable
Active, not recruiting
- Conditions
- Head and Neck CancerDysphagia
- Interventions
- Other: Acoustic cough features analysis
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 40
- Registration Number
- NCT05865756
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
Multidisciplinary Approach to Fatigue
Not Applicable
Recruiting
- Conditions
- Breast CancerGerm Cell Tumor
- Interventions
- Other: Ergospirometry
- First Posted Date
- 2022-08-16
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 50
- Registration Number
- NCT05502224
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
Not Applicable
Recruiting
- Conditions
- Metastatic Colorectal CancerCandidate for Third-line or Subsequent Lines of TherapyUnresectable Locally Advanced Colorectal Cancer
- Interventions
- Other: Blood Sample Collection
- First Posted Date
- 2022-08-04
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 103
- Registration Number
- NCT05487248
- Locations
- 🇧🇪
Institut Jules Bordet, Anderlecht, Belgium
🇧🇪UZ Antwerpen, Antwerpen, Belgium
🇧🇪CHIREC Delta, Brussels, Belgium
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Phase 2
Recruiting
- Conditions
- MelanomaBreast CancerNon Small Cell Lung CancerNon-melanoma Skin CancerHead and Neck CancerMSI-H Colorectal CancerGastrointestinal CancerSmall Cell Lung CancerMerkel Cell CarcinomaMesothelioma, Malignant
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 441
- Registration Number
- NCT05429866
- Locations
- 🇧🇪
Institut Jules Bordet, Brussel, Anderlecht, Belgium
Advanced Cancer Patients' and Their Primary Caregivers' Willingness to Communicate About Advance Care Planning (ACP)
Recruiting
- Conditions
- Advanced Cancer
- First Posted Date
- 2022-06-22
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 600
- Registration Number
- NCT05426330
- Locations
- 🇧🇪
Institut Jules Bordet, Bruxelles, Belgium
© Copyright 2025. All Rights Reserved by MedPath